AzTrials
AzTrials

Clear Aligner Orthodontic TreatmentNCT07234149

Tooth Discoloration and Chairside Handling Time (Bonding-Debonding) in Flowable Versus Packable Composites for Clear Aligner Bonded Attachments: A Randomized Clinical Trial

A study testing flowable nanohybrid Composite Resin and Packable Microhybrid Composite Resin in people with Clear Aligner Orthodontic Treatment and Composite Attachment, run by University of Sulaimani at 2 sites in Iraq.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This randomized split-mouth clinical trial aims to compare two different composite materials used for bonding attachments in clear aligner orthodontic therapy. Twenty adult participants with Class I malocclusion and mild crowding will receive flowable nanocomposite attachments on one side of the dental arch and… Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
What is being tested?
flowable nanohybrid Composite Resin and Packable Microhybrid Composite Resin
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
2 sitesIraq
Study dates
15 Oct 2025to 16 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Adults 18-40 years.
  • patients with class l malocclusion with in which there treatment will be completed in 6 month .
  • Completed clear aligner therapy and scheduled for attachment debonding at the study clinic.
  • Permanent teeth with intact buccal enamel at assessment sites.
  • No caries, restorations, cracks, fluorosis, or hypoplasia on assessed surfaces.
  • No bleaching within 6 months prior to baseline.
Show all 10Show fewer
  • Good general health (ASA I-II) and able to provide written informed consent.
  • Satisfactory oral hygiene and gingival health (e.g., GI ≤ 1).
  • Willing and able to complete measurements: spectrophotometric shade (CIE L*, a*, b*), photographs/scans, and VAS for pain/discomfort.
  • Available for all visits and follow-up assessment.

Who cannot join

  • Patients younger than 18 or older than 40 years.
  • Patients presenting with severe or very severe anterior crowding (LII > 6 mm) or spacing will exclude from the study. Cases with posterior crossbites, open bites, or skeletal discrepancies
  • Presence of systemic diseases (ASA > II) that may affect healing, pain perception, or enamel quality.
  • Teeth with caries, restorations, fractures, enamel cracks, fluorosis, hypoplasia, or discolorations on the buccal surfaces at assessment sites.
  • Patients who have undergone tooth bleaching within the last 6 months.
  • History of major dental surgery or trauma in the study region.
Show all 10Show fewer
  • Patients with poor oral hygiene or gingival inflammation (GI > 1).
  • Pregnant or lactating women.
  • Patients with allergy or hypersensitivity to composite resins or dental adhesives.
  • Individuals unable to provide informed consent or not willing to comply with study visits.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Elaf Hussein Hasan H Hasan, BSD contact

+9647715671612

elafhussein9494@gmail.com

. Hadi Mohammad M Ismail, PHD contact

+9647702106211

hadi.ismail@univsul.edu.iq

Iraq2 sites, 2 recruiting
  • Private Orthodontic Clinic - Kirkuk

    Kirkuk, Kirkuk Governorate

    Elaf H Hasan, BSD,MSD candidate, +9647715671612, elafhussein9494@gmail.com

    Recruiting
  • Private Orthodontic Clinic - Kirkuk

    Kirkuk, Province

    Elaf H Hasan, BSD,MSD candidate, +9647715671612, elafhussein9494@gmail.com

    Hadi M Ismail, PHD, +9647702106211, hadi.ismail@univsul.edu.iq

    Not yet recruiting

Other trials in Iraq

About this study

Official title: Comparison of Color Stability, Bonding Time, and White Spot Lesion Between Flowable Nanocomposite and Packable Microhybrid Composite Used for Clear Aligner Attachments: A Split-Mouth Randomized Clinical Trial

This randomized split-mouth clinical trial aims to compare two different composite materials used for bonding attachments in clear aligner orthodontic therapy. Twenty adult participants with Class I malocclusion and mild crowding will receive flowable nanocomposite attachments on one side of the dental arch and packable microhybrid composite attachments on the opposite side. The primary outcome is the color change (ΔE) of the enamel surface after attachment removal, measured by a spectrophotometer (VITA Easyshade). Secondary outcomes include bonding and debonding time and changes in enamel surface roughness before and after treatment. The study will be conducted at the Orthodontic Department, College of Dentistry, University of Sulaimani. The goal is to determine which composite material provides better color stability, easier handling, and minimal impact on enamel surface characteristics during clear aligner therapy.

Read the detailed description

Clear aligner therapy has become a popular alternative to conventional fixed orthodontic appliances due to its superior esthetics and comfort. However, the efficiency of aligner treatment often depends on the proper use of composite attachments that enhance tooth movement and retention. Different composite resins are used for this purpose, but their optical stability and effect on enamel integrity after removal remain concerns.

This prospective, split-mouth randomized clinical trial compares a flowable nanocomposite and a packable microhybrid composite used for clear aligner attachments. Each participant will receive both materials in opposite quadrants to minimize inter-individual variability. Outcomes will include enamel color change (ΔE CIE Lab* values), bonding/debonding time, and surface roughness assessment using digital and optical analysis methods.

The study hypothesis is that the flowable nanocomposite will exhibit superior color stability and faster handling time, with comparable enamel surface effects to the packable composite. Results from this trial may help establish standardized protocols for attachment material selection in clinical orthodontic practice.

Being tested
flowable nanohybrid Composite Resin, Packable Microhybrid Composite Resin
Keywords
Composite Attachment Flowable Nanocomposite Packable Microhybrid Composite

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • flowable nanohybrid Composite ResinDevice

    Also called packable microhybrid composite

    A flowable nanocomposite (e.g., GC aligne connect) used to fabricate clear aligner attachments on enamel surfaces for comparison

  • Packable Microhybrid Composite ResinDevice

    Packable microhybrid composite resin used to fabricate clear aligner attachments.

Study groups in NCT07234149
Study groupRoleWhat they receive
packable microcomposite (Group A)ExperimentalParticipants will receive packable microcomposite attachments (e.g., GC G-ænial Universal ) on one side of the dental arc attachments on one quadrant of the dental arch for clear aligner therapy. Color change, bonding/debonding time, and enamel roughness will be assessed
Receives: Device: Packable Microhybrid Composite Resin
flowable nanohybrid Composite (Group B)Active comparatorParticipants will receive flowable nanocomposite (e.g., GC aligner connect ) attachments on the opposite quadrant of the same dental arch.Color change, bonding/debonding time, and enamel roughness will be assessed.
Receives: Device: flowable nanohybrid Composite Resin

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Tooth Color (ΔE) After Attachment Removal

    The color change (ΔE) of the enamel surface will be measured using a VITA Easyshade spectrophotometer based on CIE Lab* values before bonding and after debonding of the attachments. A ΔE value ≥ 3.3 will be considered clinically perceptible.

    Measured: Baseline (before bonding) and after attachment removal

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Nov 2025
  2. Study start15 Oct 2025
  3. Primary completion15 Jul 2026 (estimated)
  4. Study completion16 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Split-mouth randomized clinical trial in which each participant receives both interventions on opposite quadrants.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07234149
Sponsor's protocol ID
USulaimani-Ortho-Aligner-2025
Other IDs
MSc-Ortho-Aligner-Study-2025;
Status last verified
Nov 2025
First submitted
14 Nov 2025
Last updated
18 Nov 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: ot applicable. Individual participant data will not be shared. Only summarized results will be published.

Publications

  • Lin S, Huang L, Li J, Wen J, Mei L, Xu H, Zhang L, Li H. Assessment of preparation time and 1-year Invisalign aligner attachment survival using flowable and packable composites. Angle Orthod. 2021 Sep 1;91(5):583-589. doi: 10.2319/063020-598.1.

    PubMed 33848325

Questions about this trial

What is this clinical trial studying?

A study testing flowable nanohybrid Composite Resin and Packable Microhybrid Composite Resin in people with Clear Aligner Orthodontic Treatment and Composite Attachment, run by University of Sulaimani at 2 sites in Iraq.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 18 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Iraq. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Elaf Hussein Hasan H Hasan, BSD (+9647715671612, elafhussein9494@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Tooth Color (ΔE) After Attachment Removal (time frame: Baseline (before bonding) and after attachment removal). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07234149, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in